Cancer patients often experience weight loss associated with cachexia, which can significantly impact the effectiveness of cancer treatments. That includes treatments such as immunotherapy and CAR T-cell therapy. A recent study showed that preventing weight loss can make treatments more effective. The study, published in the journal Blood Advances, found that cancer patients who lost…
GLP-1 drugs for weight loss have become popular because they’re very effective. But there are some significant risks that may not be readily apparent to patients — most notably the potential for muscle loss. GLP-1s helps regulate blood sugar levels, appetite and satiety. This class of drugs enhances insulin secretion, suppresses glucagon release, slows gastric…
A study recently published in the Lancet paints a grim picture of the obesity epidemic in the United States: nearly three quarters of adults in the U.S. are classified as overweight or obese. The health risks associated with this are significant and include diabetes, high blood pressure, heart disease, and shortened lifespan. As a company…
As scientists research treatments for cachexia, a wasting syndrome characterized by significant involuntary weight loss and muscle atrophy, there is a growing recognition that medications for this condition need to target the brain. There is currently no drug on the market in the U.S. that effectively treats cachexia, which is typically associated with cancer and…